Project Grant 2035140
Award Date
12/1/21
Completion Date
11/30/22
Dollars Obligated
$243K
Federal Agency
Division of Industrial Innovation
Awardee
Epirus, Inc. (JJKVLHAMFJT9)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Hawthorne, CA 90250, USA
Similar Awards
The National Science Foundation awarded a $255,981 Small Business Innovation Research Phase I Project Grant to Frezent Biological Solutions Inc. of Valhalla, NY under the Engineering (CFDA 47.041) federal grant program. The grant funds the development of a novel peptide inhibitor of the coronavirus papain-like protease as a prophylactic and antiviral therapeutic for COVID-19, to be administered via inhalation. The Engineering program seeks to improve quality of life and economic strength...
The National Science Foundation Division of Industrial Innovation awarded a $254,278 Project Grant to Silivhere Technologies Inc. under the Engineering (47.041) federal grant program. The grant supports the development of a tablet to destroy viruses, bacteria, and protozoa in stored household water from December 1, 2021 to November 30, 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award...
This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...
Eradivir Inc. received a $256,000 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation to develop a therapeutic molecule for COVID-19. Under the grant, awarded February 15, 2021 for the period through January 31, 2022, Eradivir will conduct research at its facilities in West Lafayette, Indiana under the NSF's Engineering program (CFDA #47.041). The Engineering program seeks to improve quality of life and economic strength through fostering...
This $247,457 National Science Foundation project grant funded research on coupling COVID-19 respiratory droplet adsorption and photocatalysis through metal organic frameworks. The grant was awarded to Framergy Inc. on June 15, 2021 under the Engineering (47.041) federal grant program. The objective was to develop materials and techniques to capture and deactivate SARS-CoV-2 virus particles through the end date of November 30, 2021. The Engineering program seeks to improve quality of life and...
The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Avior Inc., doing business as Avior Bio, to develop a safe and effective copper nanoparticle suspension formulation for face mask applications against SARS-CoV-2 and other viruses. The grant period runs from July 1, 2021 through December 31, 2021 under the Engineering (47.041) federal grant program. Through this funding, Avior Bio will work to produce a nanoparticle formulation that can be...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to White Rock Therapeutics under the Engineering federal grant program (CFDA 47.041). The grant will support development of an ACE2 decoy as a pan-coronavirus therapeutic from January 2022 to December 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will fund initial research...
The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...
The National Science Foundation awarded Northeastern University a $116,663 Project Grant under the Engineering federal grant program (CFDA 47.041) to host a pandemic preparedness workshop from February 15-19, 2021. The workshop, titled "PIPP WORKSHOP: PANDEMIC READINESS FOR EMERGING PATHOGENS (PREP)," will bring together experts to discuss strategies for improving readiness for future pandemics. The Engineering program seeks to advance innovation and excellence in engineering...